These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6880788)

  • 21. Estimation of acute oral toxicity in rats by determination of the approximate lethal dose rather than the LD50.
    Kennedy GL; Ferenz RL; Burgess BA
    J Appl Toxicol; 1986 Jun; 6(3):145-8. PubMed ID: 3722708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction of animal use for toxicological evaluation: the Netherlands Health Council report on the LD50.
    van Noordwijk J; Seegers AJ
    Dev Biol Stand; 1986; 64():277-85. PubMed ID: 3792652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
    Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL
    Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Shortcomings of alternative techniques for the assessment of acute toxicity.
    Rowan A
    Acta Pharmacol Toxicol (Copenh); 1983; 52 Suppl 2():190-200. PubMed ID: 6880780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In-vitro techniques: can they replace animal testing?
    Pearson RM
    Hum Reprod; 1986 Dec; 1(8):559-60. PubMed ID: 3818914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new approach to practical acute toxicity testing.
    Lorke D
    Arch Toxicol; 1983 Dec; 54(4):275-87. PubMed ID: 6667118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and validation of an ontology-driven animal-free testing strategy for developmental neurotoxicity testing.
    Hessel EVS; Staal YCM; Piersma AH
    Toxicol Appl Pharmacol; 2018 Sep; 354():136-152. PubMed ID: 29544899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro toxicity: mechanisms, alternatives and validation - a report from the 19th annual scientific meeting of the Scandinavian Society for Cell Toxicology.
    Forsby A
    Altern Lab Anim; 2002; 30(3):307-8. PubMed ID: 12106008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First CFN symposium: LD50 and possible alternatives. Proceedings of a symposium at Uppsala Bio-Medical Center, Sweden, September 15-16, 1981.
    Acta Pharmacol Toxicol (Copenh); 1983; 52 Suppl 2():1-302. PubMed ID: 6880776
    [No Abstract]   [Full Text] [Related]  

  • 30. [Is the prediction of LD50 using cell cultures generally valid?].
    Halle W; Göres E; Baeger I
    Pharmazie; 1987 Dec; 42(12):848-50. PubMed ID: 3444850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The FRAME interlaboratory programme on in vitro cytotoxicology.
    Balls M; Horner SA
    Food Chem Toxicol; 1985 Feb; 23(2):209-13. PubMed ID: 4040068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of the LD50-test for the toxicological evaluation of chemical substances.
    Zbinden G; Flury-Roversi M
    Arch Toxicol; 1981 Apr; 47(2):77-99. PubMed ID: 7271444
    [No Abstract]   [Full Text] [Related]  

  • 33. Stem cell-derived systems in toxicology assessment.
    Suter-Dick L; Alves PM; Blaauboer BJ; Bremm KD; Brito C; Coecke S; Flick B; Fowler P; Hescheler J; Ingelman-Sundberg M; Jennings P; Kelm JM; Manou I; Mistry P; Moretto A; Roth A; Stedman D; van de Water B; Beilmann M
    Stem Cells Dev; 2015 Jun; 24(11):1284-96. PubMed ID: 25675366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of two alternative methods for predicting the in vivo toxicities of metallic compounds.
    Hulme LM; Reeves HL; Clothier RH; Smith M; Balls M
    Mol Toxicol; 1987-1988 Fall; 1(4):589-96. PubMed ID: 3509705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Referring to the paper by Zbinden and Flury-Roversi. Significance of the LD50 test for toxicological evaluation of chemical substances.
    Griffin JP
    Arch Toxicol; 1981 Nov; 49(1):99-103. PubMed ID: 7325805
    [No Abstract]   [Full Text] [Related]  

  • 36. Validation of alternative toxicity test systems: lessons learned and to be learned.
    Balls M; Clothier R
    Mol Toxicol; 1987-1988 Fall; 1(4):547-59. PubMed ID: 3509701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A toxicity estimation model.
    Enslein K
    J Environ Pathol Toxicol; 1978; 2(1):115-21. PubMed ID: 722214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro assay of cytotoxicity with cultured liver: accomplishments and possibilities.
    Grisham JW; Charlton RK; Kaufman DG
    Environ Health Perspect; 1978 Aug; 25():161-71. PubMed ID: 363407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The integrated acute systemic toxicity project (ACuteTox) for the optimisation and validation of alternative in vitro tests.
    Clemedson C; Kolman A; Forsby A
    Altern Lab Anim; 2007 Mar; 35(1):33-8. PubMed ID: 17411349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [In vitro methods and their use in toxicology].
    Hurná E
    Vet Med (Praha); 1997 Jul; 42(7):213-5. PubMed ID: 9304279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.